Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanezumab open-label extension in knee osteoarthritis pain
NCT00399490Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2006
- Primary completion
- Feb 2008
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tanezumab in osteoarthritis (OA), sponsored by Pfizer. Started Sep 2006; status: completed.
02
Drugs
tanezumab
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00399490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00399490.